Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction. (Q53089236)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 November 2013

Language	Label	Description	Also known as
English	Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.	scientific article published on 8 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

6

object named as

Timothy M Pawlik

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

author name string

Susanne Bonekamp

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

David Bonekamp

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

Jean-Francois H Geschwind

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

Celia Pamela Corona-Villalobos

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

Diane K Reyes

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

Ihab R Kamel

7

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

publication date

8 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

Journal of Magnetic Resonance Imaging

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

40

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

1103-1111

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

describes a project that uses

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembo

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

High-resolution double arterial phase hepatic MRI using adaptive 2D centric view ordering: initial clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Radiologic Monitoring of Hepatocellular Carcinoma Tumor Viability after Transhepatic Arterial Chemoembolization: Estimating the Accuracy of Contrast-enhanced Cross-sectional Imaging with Histopathologic Correlation

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Evaluation of Nonenhancing Tumor Fraction Assessed by Dynamic Contrast-Enhanced MRI Subtraction as a Predictor of Decrease in Tumor Volume in Response to Chemoradiotherapy in Advanced Cervical Cancer

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.24465

21 January 2018

Identifiers

10.1002/JMRI.24465

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24214827

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53089236&oldid=1877236149"